Replimune Group, Inc. (REPL)
6.98
+0.09
(+1.31%)
USD |
NASDAQ |
Mar 20, 16:00
7.00
+0.02
(+0.29%)
After-Hours: 20:00
Replimune Group Price : 6.98 for March 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 8.10 |
| ANI Pharmaceuticals, Inc. | 74.67 |
| Phathom Pharmaceuticals, Inc. | 11.21 |
| Catalyst Pharmaceuticals, Inc. | 22.79 |
| Sarepta Therapeutics, Inc. | 16.69 |
Price Related Metrics
| PEG Ratio | -0.1396 |
| Price to Book Value | 2.738 |
| Earnings Yield | -51.33% |
| Market Cap | 576.36M |
| PEGY Ratio | -0.1396 |